Pure and Applied Chemistry, 2012, Volume 84, No. 7, pp. 1479-1542, References

Pure Appl. Chem., 2012, Vol. 84, No. 7, pp. 1479-1542

http://dx.doi.org/10.1351/PAC-CON-12-02-13

Published online 2012-06-26

Analogue-based drug discovery: Contributions to medicinal chemistry principles and drug design strategies. Microtubule stabilizers as a case in point (Special Topic Article)

Mohammad H. El-Dakdouki¹ and Paul W. Erhardt²*

¹ Department of Chemistry, Michigan State University, East Lansing, MI 48824, USA
² Center for Drug Design and Development, University of Toledo, Toledo, OH 43606, USA

References

1. J. Fischer, C. R. Ganellin. Analogue-based Drug Discovery, Wiley-VCH, Weinheim (2006).
2. J. Fischer, C. R. Ganellin. Analogue-based Drug Discovery II, Wiley-VCH, Weinheim (2010).
3. P. W. Erhardt, M. El-Dakdouki. In Analogue-based Drug Discovery II, J. Fischer, C. R. Ganellin (Eds.), pp. 243–267, Wiley-VCH, Weinheim (2010).
4. P. W. Erhardt, L. Matos. In Analogue-based Drug Discovery, J. Fischer, C. R. Ganellin (Eds.), pp. 193–232, Wiley-VCH, Weinheim (2006).
5. M. E. Wall. In Chronicles of Drug Discovery, Vol. 3, D. Lednicer (Ed.), pp. 327–348, American Chemical Society, Washington, DC (1993).
6. G. I. George, T. T. Chen, I. Ojima, D. M. Vyas. Taxane Anticancer Agents: Basic Science and Current Status, American Chemical Society, Washington, DC (1995).
7. M. Suffness (Ed.). Taxol^®: Science and Applications, CRC Press, New York (1995).
8. D. G. I. Kingston. J. Nat. Prod. 63, 726 (2000). (http://dx.doi.org/10.1021/np000064n)
9. D. G. I. Kingston. Chem. Commun. 867 (2001). (http://dx.doi.org/10.1039/b100070p)
10. H. Itokawa, K. H. Lee. Taxus: The Genus Taxus, Taylor & Francis, New York (2003).
11. M. E. Wall, M. C. Wani. Abstracts of Papers, 153^rd National Meeting of the American Chemical Society, No. M-006, Miami Beach, FL (1967).
12. P. B. Schiff, J. Fant, S. B. Horwitz. Nature (London) 277, 665 (1979). (http://dx.doi.org/10.1038/277665a0)
13. G. Chauvière, D. Guénard, F. Picot, V. Sénilh, P. Potier. C. R. Acad. Sci. Paris II 293, 501 (1981).
14. Z. Hu, P. W. Erhardt. Org. Process Res. Dev. 1, 387 (1997). (http://dx.doi.org/10.1021/op970113b)
15. Z. M. Wang, H. C. Kolb, K. B. Sharpless. J. Org. Chem. 59, 5104 (1994). (http://dx.doi.org/10.1021/jo00096a072)
16. R. A. Holton. U.S. Patent 5274 124, Filed 2 September 1992, Issued 28 December 1993.
17. R. A. Holton, R. J. Biediger. U.S. Patent 5243 045, Filed 3 April 1992, Issued 7 September 1993.
18. R. A. Holton, R. J. Biediger, P. D. Boatman. In Taxol^®: Science and Applications, M. Suffness (Ed.), pp. 97–121, CRC Press, New York (1995).
19. M. Skwarczynski, Y. Sohma, M. Noguchi, M. Kimura, Y. Hayashi, Y. Hamada, T. Kimura, Y. Kiso. J. Med. Chem. 48, 2655 (2005). (http://dx.doi.org/10.1021/jm049344g)
20. U.S. EPA. Green 2004 Greener Synthetic Pathways Award. <http://www.epa.gov/greenchemistry/pubs/pgcc/winners/gspa04.html>.
21. S. H. Son, S. M. Choi, Y. H. Lee, K. B. Choi, S. R. Yun, J. K. Kim, H. J. Park, O. W. Kwon, E. W. Noh, J. H. Seon, Y. G. Park. Plant Cell Rep. 19, 628 (2000). (http://dx.doi.org/10.1007/s002990050784)
22. W. P. McGuire, E. K. Rowinsky, N. B. Rosenshein, F. C. Grumbine, D. S. Ettinger, D. K. Armstrong, R. C. Donehower. Ann. Intern. Med. 111, 273 (1989).
23. F. A. Holmes, R. S. Walters, R. L. Theriault, M. N. Raber, A. U. Bazdar, D. K. Frye, G. N. Hortobagyi. J. Nat. Cancer Inst. 83, 1797 (1991). (http://dx.doi.org/10.1093/jnci/83.24.1797-a)
24. J. Verweij, M. Clavel, B. Chevalier. Ann. Oncol. 5, 495 (1994).
25. R. B. Weiss, R. C. Donehover, P. H. Wiernik, T. Ohnuma, R. J. Gralla, D. L. Trump, J. Baker Jr., D. A. Van Echo, D. D. Von Hoff, B. Leyland-Jones. J. Clin. Oncol. 8, 1263 (1990).
26. A. Sparreboom, O. Van Tellingen, W. J. Nooijen, J. H. Beijnen. Cancer Res. 56, 2112 (1996).
27. J. G. Sarver, W. Klis, J. Byers, P. W. Erhardt. J. Biomol. Screen. 7, 29 (2002).
28. P. W. Erhardt. Taxane J. 3, 36 (1997).
29. G. I. George, T. C. Boge, Z. S. Cheruvallath, J. S. Clowers, G. C. B. Harriman, M. Hepperle, H. Park. In Taxol^®: Science and Applications, M. Suffness (Ed.), pp. 317–375, CRC Press, New York (1995).
30. J. N. Denis, A. E. Greene, D. Guénard, F. Guéritte-Voegelein, L. Mangatal, P. Potier. J. Am. Chem. Soc. 110, 5917 (1988). (http://dx.doi.org/10.1021/ja00225a063)
31. L. Mangatal, M. T. Adeline, D. Guénard, F. Guéritte-Voegelein, P. Potier. Tetrahedron 45, 4177 (1989). (http://dx.doi.org/10.1016/S0040-4020(01)81313-2)
32. D. Guénard, F. Guéritte-Voegelein, P. Potier. Acc. Chem. Res. 26, 160 (1993). (http://dx.doi.org/10.1021/ar00028a005)
33. E. Herranz, S. A. Biller, K. B. Sharpless. J. Am. Chem. Soc. 100, 3596 (1978). (http://dx.doi.org/10.1021/ja00479a051)
34. F. Guéritte-Voegelein, D. Guénard, F. Lavelle, M. T. Le Goff, L. Mangatal, P. Potier. J. Med. Chem. 34, 992 (1991). (http://dx.doi.org/10.1021/jm00107a017)
35. F. Lavelle, C. Fizames, F. Guéritte-Voegelein, D. Guénard, P. Potier. Proc. Am. Assoc. Cancer Res. 30, 2254 (1989).
36. M. C. Bissery, D. Guénard, F. Guéritte-Voegelein, F. Lavelle. Cancer Res. 51, 4845 (1991).
37. F. Guéritte-Voegelein, D. Guénard, J. Dubois, A. Wahl, R. Marder, R. Müller, M. Lund, L. Bricard, P. Potier. In Taxane Anticancer Agents: Basic Science and Current Status, G. I. George, T. T. Chen, I. Ojima, D. M. Vyas (Eds.), American Chemical Society, Washington, DC (1995).
38. D. P. Figgitt, L. R. Wiseman. Drugs 59, 621 (2000). (http://dx.doi.org/10.2165/00003495-200059030-00015)
39. D. M. Vyas, H. Wong, A. R. Crosswell, A. M. Casazza, J. O. Knipe, S. W. Mamber, T. W. Doyle. Bioorg. Med. Chem Lett. 3, 1357 (1993). (http://dx.doi.org/10.1016/S0960-894X(00)80348-0)
40. Intelligent Information for Physicians <www.thomsonhc.com>; Drugs; Paclitaxel; Comparison Information.
41. P. W. Erhardt, R. Khupse, J. G. Sarver, J. A. Trendel. In Burger’s Medicinal Chemistry, Drug Discovery and Development, D. Abraham (Ed.), pp 103–150, John Wiley, Hoboken, NJ (2010).
42. X. Wang, H. Itokawa, K. H. Lee. In Taxus: The Genus Taxus, H. Itokawa, K. H. Lee (Eds.), pp. 298–386, Taylor & Francis, New York (2003).
43. N. F. Magri, D. G. I. Kingston. J. Nat. Prod. 51, 2471 (1988). (http://dx.doi.org/10.1021/np50056a017)
44. H. M. Deutsch, J. A. Glinski, M. Hernandez, R. D. Haugwitz, V. L. Narayanan, M. Suffness, L. H. Zalkow. J. Med. Chem. 32, 788 (1989). (http://dx.doi.org/10.1021/jm00124a011)
45. K. C. Nicolaou, C. Riermer, M. A. Kerr, D. Rideout, W. Wrasidlo. Nature 364, 464 (1993). (http://dx.doi.org/10.1038/364464a0)
46. A. E. Mathew, M. R. Mejillano, J. P. Nath, R. H. Himes, V. Stella. J. Med. Chem. 35, 145 (1992). (http://dx.doi.org/10.1021/jm00079a019)
47. R. B. Greenwald, C. W. Gilbert, A. Pendri, C. D. Conover, J. Xia, A. Martinez. J. Med. Chem. 39, 424 (1996). (http://dx.doi.org/10.1021/jm950475e)
48. A. Pendri, C. D. Conover, R. B. Greenwald. Anti-Cancer Drug Des. 13, 387 (1998).
49. T. Yamaguchi, N. Harada, K. Ozaki, H. Arakawa, K. Oda, N. Nakanishi, K. Tsujihara, T. Hashiyama. Bioorg. Med. Chem. Lett. 9, 1639 (1999). (http://dx.doi.org/10.1016/S0960-894X(99)00257-7)
50. Y. Ueda, A. B. Mikkilineni, J. O. Knipe, W. C. Rose, A. M. Cazza, D. M. Vyas. Bioorg. Med. Chem. Lett. 3, 1761 (1993). (http://dx.doi.org/10.1016/S0960-894X(00)80058-X)
51. H. Lu, B. Li, Y. Kang, Q. Huang, Q. Chen, L. Li, C. Xu. Cancer Chemother. Pharm. 59, 175 (2007). (http://dx.doi.org/10.1007/s00280-006-0256-z)
52. S. Ansell, S. Johnstone, P. G. Tardi, L. Lo, S. Xie, Y. Shu, T. O. Harasym, N. L. Harasym, L. Williams, D. Bermudes, B. D. Liboiron, W. Saad, R. K. Prud’homme, L. D. Mayer. J. Med. Chem. 51, 3288 (2008). (http://dx.doi.org/10.1021/jm800002y)
53. F. Guéritte. Curr. Pharm. Des. 7, 1229 (2001). (http://dx.doi.org/10.2174/1381612013397429)
54. F. Gueritte-Voegelein, L. Mangatal, D. Guenard, P. Potier, J. Guilhem, M. Cesario, C. Pascard. Acta Crystallogr., Sect. C 46, 781 (1990). (http://dx.doi.org/10.1107/S0108270189009376)
55. D. Mastropaolo, A. Camerman, Y. Luo, G. D. Brayer, N. Camerman. Proc. Natl. Acad. Sci. USA 92, 6920 (1995). (http://dx.doi.org/10.1073/pnas.92.15.6920)
56. T. C. Boge, Z. J. Wu, R. H. Himes, D. G. Vander Velde, G. I. Georg. Bioorg. Med. Chem. Lett. 9, 3041 (1999). (http://dx.doi.org/10.1016/S0960-894X(99)00521-1)
57. H. J. Williams, A. I. Scott, R. A. Dieden, C. S. Swindell, L. E. Chirlian, M. M. Francl, J. M. Heerding, N. E. Krauss. Tetrahedron 49, 6545 (1993). (http://dx.doi.org/10.1016/S0040-4020(01)81823-8)
58. H. J. Williams, A. I. Scott, R. A. Dieden, C. S. Swindell, L. E. Chirlian, M. M. Francl, J. M. Heerding, N. E. Krauss. Can. J. Chem. 72, 252 (1994). (http://dx.doi.org/10.1139/v94-038)
59. D. G. Vander Velde, G. I. Georg, G. L. Grunewald, C. W. Gunn, L. A. Mitscher. J. Am. Chem. Soc. 115, 11650 (1993). (http://dx.doi.org/10.1021/ja00077a095)
60. J. Jimenez-Barbero, F. Amat-Guerri, J. P. Snyder. Curr. Med. Chem. Anticancer Agents 2, 91 (2002). (http://dx.doi.org/10.2174/1568011023354416)
61. F. Gueritte-Voegelein, D. Guenard, F. Lavelle, M. T. LeGoff, L. Mangatal, P. Potier. J. Med. Chem. 34, 992 (1991). (http://dx.doi.org/10.1021/jm00107a017)
62. C. S. Swindell, N. E. Krauss, S. B. Horwitz, I. Ringel. J. Med. Chem. 34, 1176 (1991). (http://dx.doi.org/10.1021/jm00107a042)
63. D. Guenard, F. Gueritte-Voegelein, P. Potier. Acc. Chem. Res. 26, 160 (1993). (http://dx.doi.org/10.1021/ar00028a005)
64. Q. Gao, W. L. Parker. Tetrahedron 52, 2291 (1996). (http://dx.doi.org/10.1016/0040-4020(95)01062-9)
65. Q. Gao, S. H. Chen. Tetrahedron Lett. 37, 3425 (1996). (http://dx.doi.org/10.1016/0040-4039(96)00585-0)
66. I. Ojima, S. D. Kuduk, S. Chakravarty, M. Ourevitch, J. P. Begue. J. Am. Chem. Soc. 119, 5519 (1997). (http://dx.doi.org/10.1021/ja9633777)
67. L. Gomez-Paloma, R. K. Guy, W. Wrasidlo, K. C. Nicolaou. Chem. Biol. 1, 107 (1994). (http://dx.doi.org/10.1016/1074-5521(94)90048-5)
68. S. Rao, S. B. Horwitz, I. Ringel. J. Natl. Cancer Inst. 84, 785 (1992). (http://dx.doi.org/10.1093/jnci/84.10.785)
69. L. He, G. A. Orr, S. B. Horwitz. Drug Discov. Today 6, 1153 (2001). (http://dx.doi.org/10.1016/S1359-6446(01)02038-4)
70. S. Rao, N. E. Krauss, J. M. Heerding, C. S. Swindell, I. Ringel, G. A. Orr, S. B. Horwitz. J. Biol. Chem. 269, 3132 (1994).
71. S. Rao, G. A. Orr, A. G. Chaudhary, D. G. Kingston, S. B. Horwitz. J. Biol. Chem. 270, 20235 (1995). (http://dx.doi.org/10.1074/jbc.270.34.20011)
72. S. Rao, L. He, S. Chakravarty, I. Ojima, G. A. Orr, S. B. Horwitz. J. Biol. Chem. 274, 37990 (1999). (http://dx.doi.org/10.1074/jbc.274.53.37990)
73. J. P. Snyder, J. H. Nettles, B. Cornett, K. H. Downing, E. Nogales. Proc. Natl. Acad. Sci. USA 98, 5312 (2001). (http://dx.doi.org/10.1073/pnas.051309398)
74. R. C. Weisenberg, W. J. Deery. Nature 263, 792 (1976). (http://dx.doi.org/10.1038/263792a0)
75. T. David-Pfeuty, H. P. Erickson, D. Pantaloni. Proc. Natl. Acad. Sci. USA 74, 5372 (1977). (http://dx.doi.org/10.1073/pnas.74.12.5372)
76. L. A. Amos, J. Lowe. Chem. Biol. 6, R65 (1999). (http://dx.doi.org/10.1016/S1074-5521(99)89002-4)
77. J. Lowe, L. A. Amos. Nature 391, 203 (1998). (http://dx.doi.org/10.1038/34472)
78. L. D. Belmont, T. J. Mitchison. Cell 84, 623 (1996). (http://dx.doi.org/10.1016/S0092-8674(00)81037-5)
79. E. Nogales, S. G. Wolf, K. H. Downing. Nature 391, 199 (1998). (http://dx.doi.org/10.1038/34465)
80. H. P. Erickson. Nat. Cell Biol. 2, E93 (2000). (http://dx.doi.org/10.1038/35014084)
81. P. W. Erhardt, J. R. Proudfoot. In Comprehensive Medicinal Chemistry II, Vol. 1, J. Taylor, D. Triggle (Eds.), pp. 29–96, Elsevier, Oxford (2007).
82. T. C. Boge, R. H. Himes, D. G. Vander Velde, G. I. Georg. J. Med. Chem. 37, 3337 (1994). (http://dx.doi.org/10.1021/jm00046a018)
83. S. H. Chen, J. M. Wei, B. H. Long, C. A. Fairchild, J. Carboni, S. W. Mamber, W. C. Rose, K. Johnston, A. M. Casazza. Bioorg. Med. Chem. Lett. 5, 2741 (1995). (http://dx.doi.org/10.1016/0960-894X(95)00453-Z)
84. A. G. Chaudhary, M. M. Gharpure, J. M. Rimoldi, M. D. Chordia, A. A. L. Gunatilaka, D. G. I. Kingston, S. Grover, C. Lin, E. Hamel. J. Am. Chem. Soc. 116, 4097 (1994). (http://dx.doi.org/10.1021/ja00088a063)
85. O. Querolle, J. Dubois, S. Thoret, F. Roussi, S. Montiel-Smith, F. Guéritte, D. Guénard. J. Med. Chem. 46, 3623 (2003). (http://dx.doi.org/10.1021/jm030770w)
86. O. Querolle, J. Dubois, S. Thoret, F. Roussi, S. Montiel-Smith, F. Guéritte, D. Guénard. J. Med. Chem. 47, 5937 (2004). (http://dx.doi.org/10.1021/jm0497996)
87. Y. Yang, A. A. Alcaraz, J. P. Snyder. J. Nat. Prod. 72, 422 (2009). (http://dx.doi.org/10.1021/np800662j)
88. I. Ojima, M. Das. J. Nat. Prod. 72, 554 (2009). (http://dx.doi.org/10.1021/np8006556)
89. M. A. Jordan, L. Wilson. In Taxane Anticancer Agents, G. Georg, T. Chen, I. Ojima, D. Vyas (Eds.), pp. 138–153, American Chemical Society, Washington, DC (1995).
90. J. Parness, S. B. Horwitz. J. Cell Biol. 91, 479 (1981). (http://dx.doi.org/10.1083/jcb.91.2.479)
91. J. F. Diaz, J. M. Valpeusta, P. Chacon, G. Diakun, J. M. Andreu. J. Biol. Chem. 273, 33803 (1998). (http://dx.doi.org/10.1074/jbc.273.50.33803)
92. I. Ojima, Y. H. Park, I. Fenoglio, O. Duclos, C. M. Sun, S. D. Kuduk, M. Zucco, G. Appendino, P. Pera, J. M. Veith, R. J. Bernacki, M. C. Bissery, C. Combeau, P. Vrignaud, J. F. Riou, F. Lavell. In Taxane Anticancer Agents: Basic Science and Current Status, G. I. Georg, T. T. Chen, I. Ojima, D. M. Vyas (Eds.), pp. 262–275, American Chemical Society, Washington, DC (1995).
93. I. Ojima, O. Duclos, G. Dorman, B. Simonot, G. D. Prestwich, S. Rao, K. A. Lerro, S. B. Horwitz. J. Med. Chem. 38, 3891 (1995). (http://dx.doi.org/10.1021/jm00020a001)
94. I. Ojima, J. C. Slater, E. Michaud, S. D. Kuduk, P. Y. Bounaud, P. Vrignaud, M. C. Bissery, J. Veith, P. Pera, R. J. Bernacki. J. Med. Chem. 39, 3889 (1996). (http://dx.doi.org/10.1021/jm9604080)
95. M. L. Miller, I. Ojima. Chem. Rec. 1, 195 (2001). (http://dx.doi.org/10.1002/tcr.1008)
96. I. Ojima, J. Chen, L. Sun, C. P. Borella, T. Wang, M. L. Miller, S. Lin, X. Geng, L. Kuznetsova, C. Qu, D. Gallager, X. Zhao, I. Zanardi, S. Xia, S. B. Horwitz, J. Mallen-St. Clair, J. L. Guerriero, D. Bar-Sagi, J. M. Veith, P. Pera, R. J. Bernacki. J. Med. Chem. 51, 3203 (2008). (http://dx.doi.org/10.1021/jm800086e)
97. I. Ojima, P. Y. Bounaud, C. Takeuchi, P. Pera, R. J. Bernacki. Bioorg. Med. Chem. Lett. 8, 189 (1998). (http://dx.doi.org/10.1016/S0960-894X(97)10218-9)
98. I. Ojima, P. Bounaud, R. J. Bernacki. CHEMTECH 28, 31 (1998).
99. A. Rice, Y. Liu, M. L. Michaels, R. H. Himes, G. I. Georg, K. L. Audus. J. Med. Chem. 48, 832 (2005). (http://dx.doi.org/10.1021/jm040114b)
100. J. T. Spletstoser, B. J. Turunen, K. Desino, A. Rice, A. Datta, D. Dutta, J. K. Huff, R. H. Himes, K. L. Audus, A. Seeling, G. I. Georg. Bioorg. Med. Chem. Lett. 16, 495 (2006). (http://dx.doi.org/10.1016/j.bmcl.2005.10.063)
101. P. W. Erhardt. Pure Appl. Chem. 74, 703 (2002). (http://dx.doi.org/10.1351/pac200274050703)
102. P. W. Erhardt, W. Klis, J. G. Sarver. Paclitaxel hybrid derivatives. World Patent Application WO 2004/080412 A2, Filed 05 March 2004, Issued 23 September 2004.
103. W. Klis, J. G. Sarver, P. W. Erhardt. Synth. Commun. 32, 2711 (2002). (http://dx.doi.org/10.1081/SCC-120006037)
104. W. Klis, J. G. Sarver, P. W. Erhardt. Tetrahedron Lett. 42, 7747 (2001). (http://dx.doi.org/10.1016/S0040-4039(01)01643-4)
105. W. Klis, J. G. Sarver, P. W. Erhardt. U.S. Patent 6846937 B2, Filed 27 September 2002, Issued 25 January 2005.
106. L. B. Michaud, V. Valero, G. Hortobagyi. Drug Saf. 23, 401 (2000). (http://dx.doi.org/10.2165/00002018-200023050-00005)
107. F. Kratz, I. A. Muller, C. Ryppa, A. Warnecke. ChemMedChem 3, 20 (2008). (http://dx.doi.org/10.1002/cmdc.200700159)
108. H. M. Ellerby, W. Arap, L. M. Ellerby, R. Kain, R. Andrusiak, G. D. Rio, S. Krajewski, C. R. Lombardo, R. Rao, E. Ruoslahti, D. E. Bredesen, R. Pasqualini. Nat. Med. 5, 1032 (1999).
109. B. G. Wouters, S. A. Weppler, M. Koritzinsky, W. Landuyt, S. Nuyts, J. Theys, R. K. Chiu, P. Lambin. Eur. J. Cancer 38, 240 (2002). (http://dx.doi.org/10.1016/S0959-8049(01)00361-6)
110. P. Ettmayer, G. L. Amidon, B. Clement, B. Testa. J. Med. Chem. 47, 2393 (2004). (http://dx.doi.org/10.1021/jm0303812)
111. T. G. Metzger, M. G. Paterlini, P. S. Portoghese, D. M. Ferguson. Neurochem. Res. 21, 1287 (1996). (http://dx.doi.org/10.1007/BF02532369)
112. S. Jaracz, J. Chen, L. V. Kuznetsova, I. Ojima. Bioorg. Med. Chem. 13, 5043 (2005). (http://dx.doi.org/10.1016/j.bmc.2005.04.084)
113. P. S. Huang, A. Oliff. Curr. Opin. Genet. Dev. 11, 104 (2001). (http://dx.doi.org/10.1016/S0959-437X(00)00164-7)
114. V. J. Stella. Exp. Opin. Ther. Pat. 14, 277 (2004). (http://dx.doi.org/10.1517/13543776.14.3.277)
115. P. W. Erhardt, M. D. Reese. In Prodrugs and Targeted Delivery, J. Rautio (Ed.), pp. 385–413, Wiley-VCH, Weinheim (2011).
116. E. W. P. Damen, P. H. G. Weigerinck, L. Braamer, D. Sperling, D. de Vos, H. W. Scheeren. Bioorg. Med. Chem. 8, 427 (2000). (http://dx.doi.org/10.1016/S0968-0896(99)00301-6)
117. Z. Zhao, D. G. I. Kingston, A. R. Crosswell. J. Nat. Prod. 54, 1607 (1991). (http://dx.doi.org/10.1021/np50078a018)
118. A. E. Mathew, M. R. Mejillano, J. P. Nath, R. H. Himes, V. J. Stella. J. Med. Chem. 35, 145 (1992). (http://dx.doi.org/10.1021/jm00079a019)
119. Y. Hayashi, M. Skwarczynski, Y. Hamada, Y. Sohma, T. Kimura, Y. Kiso. J. Med. Chem. 46, 3782 (2003). (http://dx.doi.org/10.1021/jm034112n)
120. Y. Sohma, Y. Hayashi, M. Skwarczynski, Y. Hamada, M. Sasaki, T. Kimura, Y. Kiso. Biopolymers 76, 344 (2004). (http://dx.doi.org/10.1002/bip.20136)
121. M. Skwarczynski, Y. Sohma, M. Noguchi, M. Kimura, Y. Hayashi, Y. Hamada, T. Kimura, Y. Kiso. J. Med. Chem. 48, 2655 (2005). (http://dx.doi.org/10.1021/jm049344g)
122. S. Lin, I. Ojima. Exp. Opin. Ther. Pat. 10, 869 (2000). (http://dx.doi.org/10.1517/13543776.10.6.869)
123. M. Skwarczynski, Y. Hayashi, Y. Kiso. J. Med. Chem. 49, 7253 (2006). (http://dx.doi.org/10.1021/jm0602155)
124. M. Skwarczynski, Y. Kiso. Curr. Med. Chem. 14, 2813 (2007). (http://dx.doi.org/10.2174/092986707782360123)
125. A. A. Moosavi-Movahedi, S. Hakimelahi, J. Chamani, G. A. Khodarahmi, F. Hassanzadeh, F. T. Luo, T. W. Ly, K. S. Shia, C. F. Yen, M. L. Jain, R. Kulatheeswaran, C. Xue, M. Pasdar, G. H. Hakimelahi. Bioorg. Med. Chem. 11, 4303 (2003). (http://dx.doi.org/10.1016/S0968-0896(03)00524-8)
126. A. L. Seligson, R. C. Terry, J. C. Bressi, J. G. Douglass III, M. Sovak. Anti-Cancer Drugs. 12, 305 (2001). (http://dx.doi.org/10.1097/00001813-200104000-00002)
127. E. W. P. Damen, T. J. Nevalainen, T. J. M. van den Berg, F. M. H de Groot, H. W. Scheeren. Bioorg. Med. Chem. 10, 71 (2002). (http://dx.doi.org/10.1016/S0968-0896(01)00235-8)
128. V. M. Vrudhula, J. F. MacMaster, Z. Li, D. E. Kerr, P. D. Senter. Bioorg. Med. Chem. Lett. 12, 3591 (2002). (http://dx.doi.org/10.1016/S0960-894X(02)00784-9)
129. E. L. Eliel. In Stereochemistry of Carbon Compounds, p. 197, McGraw Hill, New York (1962).
130. S. R. Denmeade, A. Nagy, J. Gao, H. Lilja, A. V. Schally, J. T. Isaacs. Cancer Res. 58, 2537 (1998).
131. S. R. Khan, S. R. Denmeade. Prostate 45, 80 (2000). (http://dx.doi.org/10.1002/1097-0045(20000915)45:1<80::AID-PROS10>3.0.CO;2-Q)
132. S. K. Kumar, S. A. Williams, J. T. Isaacs, S. R. Denmeade, S. R. Khan. Bioorg. Med. Chem. 15, 4973 (2007). (http://dx.doi.org/10.1016/j.bmc.2007.04.029)
133. F. M. H.de Groot, L. W. A. van Berkom, H. W. Scheeren. J. Med. Chem. 43, 3093 (2000). (http://dx.doi.org/10.1021/jm0009078)
134. Y. I. Yamashita, M. Ogawa. Int. J. Oncol. 10, 807 (1997).
135. H. Graeff, M. Schmitt. Int. J. Oncol. 13, 893 (1998).
136. R. V. J. Chari. Adv. Drug Delivery Rev. 31, 89 (1998). (http://dx.doi.org/10.1016/S0169-409X(97)00095-1)
137. I. Ojima, X. Geng, X. Wu, C. Qu, C. P. Borella, H. Xie, S. D. Wilhelm, B. A. Leece, L. M. Bartle, V. S. Goldmacher, R. V. J. Chari. J. Med. Chem. 45, 5620 (2002). (http://dx.doi.org/10.1021/jm025540g)
138. K. D. Bagshawe, S. K. Sharma, R. H. J. Begent. Exp. Opin. Biol. Ther. 4, 1777 (2004). (http://dx.doi.org/10.1517/14712598.4.11.1777)
139. G. Xu, H. L. McLeod. Clin. Cancer Res. 7, 3314 (2001).
140. M. L. Rodrigues, P. Carter, C. Wirth, S. Mullins, A. Lee, B. K. Blackburn. Chem. Biol. 2, 223 (1995). (http://dx.doi.org/10.1016/1074-5521(95)90272-4)
141. M. L. Rodrigues, L. G. Presta, C. E. Kotts, C. Wirth, J. Mordenti, G. Osaka, W. L. T. Wong, A. Nuijens, B. Blackburn, P. Carter. Cancer Res. 55, 63 (1995).
142. V. M. Vrudhula, D. E. Kerr, N. O. Siemers, G. M. Dubowchik, P. D. Senter. Bioorg. Med. Chem. Lett. 13, 539 (2003). (http://dx.doi.org/10.1016/S0960-894X(02)00935-6)
143. M. De Graaf, E. Boven, H. W. Scheeren, H. J. Haisma, H. M. Pinedo. Curr. Pharm. Des. 8, 1391 (2002). (http://dx.doi.org/10.2174/1381612023394485)
144. D. B. A.de Bont, R. G. G. Leenders, H. J. Haisma, I. Van der Meulen-Muileman, H. W. Scheeren. Bioorg. Med. Chem. 5, 405 (1997). (http://dx.doi.org/10.1016/S0968-0896(96)00249-0)
145. F. Schmidt, I. Ungureanu, R. Duval, A. Pompon, C. Monneret. Eur. J. Org. Chem. 11, 2129 (2001). (http://dx.doi.org/10.1002/1099-0690(200106)2001:11<2129::AID-EJOC2129>3.0.CO;2-#)
146. E. Bouvier, S. Thirot, F. Schmidt, C. Monneret. Org. Biomol. Chem. 1, 3343 (2003). (http://dx.doi.org/10.1039/b306236h)
147. S. Jain, W. B. Drendel, Z. W. Chen, F. S. Mathews, W. S. Sly, J. H. Grubb. Nat. Struct. Biol. 3, 375 (1996). (http://dx.doi.org/10.1038/nsb0496-375)
148. B. Sperker, J. T. Backman, H. K. Kroemer. Clin. Pharmacokinet. 33, 18 (1997). (http://dx.doi.org/10.2165/00003088-199733010-00003)
149. A. El Alaoui, N. Saha, F. Schmidt, C. Monneret, J. C. Florent. Bioorg. Med. Chem. 14, 5012 (2006). (http://dx.doi.org/10.1016/j.bmc.2006.03.002)
150. W. C. Heird, A. Lapillonne. Annu. Rev. Nutr. 25, 549 (2005). (http://dx.doi.org/10.1146/annurev.nutr.24.012003.132254)
151. L. A. Sauer, R. T. Dauchy. Biochem. Soc. Trans. 18, 80 (1990).
152. M. O. Bradley, N. L. Webb, F. H. Anthony, P. Devanesan, P. A. Witman, S. Hemamalini, M. C. Chander, S. D. Baker, L. He, S. B. Horwitz, C. S. Swindell. Clin. Cancer Res. 7, 3229 (2001).
153. L. Kuznetsova, J. Chen, L. Sun, X. Wu, A. Pepe, J. M. Veith, P. Pera, R. J. Bernacki, I. Ojima. Bioorg. Med. Chem. Lett. 16, 974 (2006). (http://dx.doi.org/10.1016/j.bmcl.2005.10.089)
154. Y. S. Lin, R. Tungpradit, S. Sinchaikul, F. M. An, D. Z. Liu, S. Phutrakul, S. T. Chen. J. Med. Chem. 51, 7428 (2008). (http://dx.doi.org/10.1021/jm8006257)
155. A. R. Collins. Eur. J. Cancer 41, 1923 (2005). (http://dx.doi.org/10.1016/j.ejca.2005.06.004)
156. K. A. Conklin. Nutr. Cancer 37, 1 (2000). (http://dx.doi.org/10.1207/S15327914NC3701_1)
157. K. Nakagawa-Goto, K. Yamada, S. Nakamura, T. H. Chen, P. C. Chiang, K. F. Bastow, S. C. Wang, B. Spohn, M. C. Hung, F. Y. Lee, F. C. Lee, K. H. Lee. Bioorg. Med. Chem. Lett. 17, 5204 (2007). (http://dx.doi.org/10.1016/j.bmcl.2007.06.083)
158. Q. Shi, H.-K. Wang, K. F. Bastow, Y. Tachibana, K. Chen, F.-Y. Lee, K.-H. Lee. Bioorg. Med. Chem. 9, 2999 (2001). (http://dx.doi.org/10.1016/S0968-0896(01)00206-1)
159. D. D. Gibbs, D. S. Theti, N. Wood, M. Green, F. Raynaud, M. Valenti, M. D. Forster, F. Mitchell, V. Bavetsias, E. Henderson, A. L. Jackman. Cancer Res. 65, 11721 (2005). (http://dx.doi.org/10.1158/0008-5472.CAN-05-2034)
160. H. Elnakat, M. Ratnam. Adv. Drug Deliv. Rev. 56, 1067 (2004). (http://dx.doi.org/10.1016/j.addr.2004.01.001)
161. C. P. Leamon, J. A. Reddy. Adv. Drug Deliv. Rev. 56, 1127 (2004). (http://dx.doi.org/10.1016/j.addr.2004.01.008)
162. J. W. Lee, J. Y. Lu, P. S. Low, P. L. Fuchs. Bioorg. Med. Chem. 10, 2397 (2002). (http://dx.doi.org/10.1016/S0968-0896(02)00019-6)
163. I. J. Majoros, A. Myc, T. Thomas, C. B. Mehta, J. R. J. Becker. Biomacromolecules 7, 572 (2006). (http://dx.doi.org/10.1021/bm0506142)
164. P. S. Low, W. A. Henne, D. D. Doorneweerd. Acc. Chem. Res. 41, 120 (2008). (http://dx.doi.org/10.1021/ar7000815)
165. I. Ojima. Acc. Chem. Res. 41, 108 (2008). (http://dx.doi.org/10.1021/ar700093f)
166. C. Liu, J. S. Strobl, S. Bane, J. Schilling, M. McCracken, S. K. Chatterjee, R. Rahim-Bata, D. G. I. Kingston. J. Nat. Prod. 67, 152 (2004). (http://dx.doi.org/10.1021/np030296x)
167. S. D. Kuduk, F. F. Zheng, L. Sepp-Lorenzino, N. Rosen, S. J. Danishefsky. Bioorg. Med. Chem. Lett. 9, 1233 (1999). (http://dx.doi.org/10.1016/S0960-894X(99)00185-7)
168. S. D. Kuduk, C. R. Harris, F. F. Zheng, L. Sepp-Lorenzino, Q. Ouerfelli, N. Rosen, S. J. Danishefsky. Bioorg. Med. Chem. Lett. 10, 1303 (2000). (http://dx.doi.org/10.1016/S0960-894X(00)00208-0)
169. A. Safavy, K. P. Raisch, M. B. Khazaeli, D. J. Buchsbaum, J. A. Bonner. J. Med. Chem. 42, 4919 (1999). (http://dx.doi.org/10.1021/jm990355x)
170. J. Zhou, J. Chen, R. Zhong, M. Mokotoff, L. D. Shultz, E. D. Ball. Clin. Cancer Res. 12, 2224 (2006). (http://dx.doi.org/10.1158/1078-0432.CCR-05-1524)
171. H. Maeda. Adv. Enzyme Regul. 41, 189 (2001). (http://dx.doi.org/10.1016/S0065-2571(00)00013-3)
172. H. Maeda, T. Sawa, T. Konno. J. Controlled Release 74, 47 (2001). (http://dx.doi.org/10.1016/S0168-3659(01)00309-1)
173. K. Hoste, K. De Winne, E. Schacht. Int. J. Pharm. 277, 119 (2004). (http://dx.doi.org/10.1016/j.ijpharm.2003.07.016)
174. R. B. Greenwald, A. Pendri, D. Bolikal, C. W. Gilbert. Bioorg. Med. Chem. Lett. 4, 2465 (1994). (http://dx.doi.org/10.1016/S0960-894X(01)80411-X)
175. P. C. A. Rodrigues, K. Scheuermann, C. Stockmar, G. Maier, H. H. Fiebig, C. Unger, R. Muelhaupt, F. Kratz. Bioorg. Med. Chem. Lett. 13, 355 (2003). (http://dx.doi.org/10.1016/S0960-894X(02)01002-8)
176. J. S. Choi, B. W. Jo. Int. J. Pharm. 280, 221 (2004). (http://dx.doi.org/10.1016/j.ijpharm.2004.05.014)
177. C. Li, D. F. Yu, R. A. Newman, F. Cabral, L. C. Stephens, N. Hunter, L. Milas, S. Wallace. Cancer Res. 58, 2404 (1998).
178. C. Li, J. E. Price, L. Milas, N. R. Hunter, S. Ke, D. F. Yu, C. Charnsangavej, S. Wallace. Clin. Cancer Res. 5, 891 (1999).
179. S. A. Shaffer, C. Baker-Lee, J. Kennedy, M. S. Lai, P. de Vries, K. Buhler, J. W. Singer. Cancer Chemother. Pharmacol. 59, 537 (2007). (http://dx.doi.org/10.1007/s00280-006-0296-4)
180. C. Bicamumpaka, M. Page. Oncol. Rep. 5, 1381 (1998).
181. F. Dosio, P. Brusa, P. Crosasso, S. Arpicco, L. Cattel. J. Controlled Release 47, 293 (1997). (http://dx.doi.org/10.1016/S0168-3659(97)01656-8)
182. F. Dosio, S. Arpicco, P. Brusa, B. Stella, L. Cattel. J. Controlled Release 76, 107 (2001). (http://dx.doi.org/10.1016/S0168-3659(01)00420-5)
183. F. M. H. De Groot, C. Albrecht, R. Koekkoek, P. H. Beusker, H. W. Scheeren. Angew. Chem., Int. Ed. 42, 4490 (2003). (http://dx.doi.org/10.1002/anie.200351942)
184. D. A. Tomalia, A. M. Naylor, W. A. Goddard III. Angew. Chem., Int. Ed. 102, 119 (1990).
185. G. R. Newkome, A. Nyak, R. K. Behera, C. N. Moorefield, G. R. Baker. J. Org. Chem. 57, 358 (1990). (http://dx.doi.org/10.1021/jo00027a061)
186. P. Ehrlich. Lancet 16, 445 (1913).
187. J. Bronson, M. Dhar, W. Ewing, N. Lonberg. Ann. Rep. Med. Chem. 46, 433 (2011). (http://dx.doi.org/10.1016/B978-0-12-386009-5.00002-3)
188. M. C. Bissery, H. Bouchard, J. F. Riou, P. Vrignaud, C. Combeau, J. D. Bourzat, A. Commercon, F. Lavelle. Proc. Am. Assoc. Cancer Res. 41, Abstract 1364 (2000).
189. P. Vrignaud, P. Lejeune, D. Chaplin, F. Lavelle, M. C. Bissery. Proc. Am. Assoc. Cancer Res. 41, Abstract 1365 (2000).
190. A. C. Mita, L. J. Denis, E. K. Rowinsky, J. S. DeBono, A. D. Goetz, L. Ochoa, B. Forouzesh, M. Beeram, A. Patnaik, K. Molpus, D. Semiond, M. Besenval, A. W. Tolcher. Clin. Cancer Res. 15, 723 (2009). (http://dx.doi.org/10.1158/1078-0432.CCR-08-0596)
191. E. Didier, G. Oddon, D. Pauze, P. Leon, D. Riguet. WO 9925704, Filed 16 November 1998, Issued 27 May 1999.
192. H. Bouchard, D. Semiond, M.-L. Risse, P. Vrignaud. In Analogue-Based Drug Discovery III, J. Fischer, C. R. Ganellin (Eds.), Wiley-VCH, Weinheim (2012). In press.
193. M. Roche, H. Kyriakou, M. Seiden. Curr. Opin. Investig. Drugs 7, 1092 (2006).
194. P. Baas, A. Szczesna, I. Albert, J. Milanowski, E. Juhasz, Z. Sztancsik, J. von Pawel, R. Oyama, S. Burgers. J. Thorac. Oncol. 3, 745 (2008). (http://dx.doi.org/10.1097/JTO.0b013e31817c73ff)
195. M. A. Jordan, L. Wilson. Nat. Cancer Rev. 4, 253 (2004). (http://dx.doi.org/10.1038/nrc1317)
196. B. R. Hearn, S. J. Shaw, D. C. Myles. Comp. Med. Chem. II 7, 81 (2006).
197. F. Feyen, F. Cachoux, J. Gertsch, M. Wartmann, K. H. Altmann. Acc. Chem. Res. 41, 21 (2008). (http://dx.doi.org/10.1021/ar700157x)
198. D. G. I. Kingston. J. Nat. Prod. 72, 507 (2009). (http://dx.doi.org/10.1021/np800568j)
199. D. C. Myles. Ann. Rep. Med. Chem. 37, 125 (2002). (http://dx.doi.org/10.1016/S0065-7743(02)37014-3)
200. K. Gerth, N. Bedorf, G. Hoefle, H. Irschik, H. Reichenbach. J. Antibiotics 49, 560 (1996). (http://dx.doi.org/10.7164/antibiotics.49.560)
201. D. M. Bollag, P. A. McQueney, J. Zhu, O. Hensens, L. Koupal, J. Liesch, M. Goetz, E. Lazarides, C. M. Woods. Cancer Res. 55, 2325 (1995).
202a. S. P. Gunasekera, M. Gunasekera, R. E. Longley, G. K. Schulte. J. Org. Chem. 55, 4912 (1990). (http://dx.doi.org/10.1021/jo00303a029)
202b. S. P. Gunasekera, M. Gunasekera, R. E. Longley, G. K. Schulte. Correction: J. Org. Chem. 56, 1346 (1991). (http://dx.doi.org/10.1021/jo00003a090)
203. R. E. Longley, D. Caddigan, D. Harmody, M. Gunasekera, S. P. Gunasekera. Transplantation 52, 650 (1991). (http://dx.doi.org/10.1097/00007890-199110000-00014)
204. R. E. Longley, D. Caddigan, D. Harmody, M. Gunasekera, S. P. Gunasekera. Transplantation 52, 656 (1991). (http://dx.doi.org/10.1097/00007890-199110000-00015)
205. R. E. Longley, S. P. Gunasekera, D. Faherty, J. Mclane, F. Dumont. Ann. N.Y. Acad. Sci. 696, 94 (1993). (http://dx.doi.org/10.1111/j.1749-6632.1993.tb17145.x)
206. D. T. Hung, J. B. Nerenberg, S. L. Schreiber. Chem. Biol. 1, 67 (1994). (http://dx.doi.org/10.1016/1074-5521(94)90042-6)
207. E. ter Haar, R. J. Kowalski, E. Hamel, C. M. Lin, R. E. Longley, S. P. Gunasekera, H. S. Rosenkranz, B. W. Day. Biochemistry 35, 243 (1996). (http://dx.doi.org/10.1021/bi9515127)
208. M. Kalesse. Chembiochem 1, 171 (2000). (http://dx.doi.org/10.1002/1439-7633(20001002)1:3<171::AID-CBIC171>3.0.CO;2-D)
209. J. B. Nerenberg, D. T. Hung, P. K. Somers, S. L. Schreiber. J. Am. Chem. Soc. 115, 12621 (1993). (http://dx.doi.org/10.1021/ja00079a066)
210. A. B. Smith III, M. D. Kaufman, T. J. Beauchamp, M. LaMarche, H. Arimoto. Org. Lett. 1, 1823 (1999). (http://dx.doi.org/10.1021/ol9910870)
211. S. J. Mickel. Curr. Opin. Drug Disc. Dev. 7, 869 (2004).
212. T. Lindel, P. R. Jensen, W. Fenical, B. H. Long, A. M. Casazza, J. Carboni, C. R. Fairchild. J. Am. Chem. Soc. 119, 8744 (1997). (http://dx.doi.org/10.1021/ja9717828)
213. M. D’Ambrosio, A. Guerriero, F. Pietra. Helv. Chim. Acta 70, 2019 (1987). (http://dx.doi.org/10.1002/hlca.19870700807)
214. B. H. Long, J. M. Carboni, A. J. Wasserman, L. A. Cornell, A. M. Casazza, P. R. Jensen, T. Lindel, W. Fenical, C. R. Fairchild. Cancer Res. 58, 1111 (1998).
215. K. C. Nicolaou, N. Winssinger, D. Vourloumis, T. Ohshima, S. Kim, J. Pfefferkorn, J. Y. Xu, T. Li. J. Am. Chem. Soc. 120, 10814 (1998). (http://dx.doi.org/10.1021/ja9823870)
216. D. G. Corley, R. Herb, R. E. Moore, P. J. Scheuer, V. J. Paul. J. Org. Chem. 53, 644 (1988). (http://dx.doi.org/10.1021/jo00250a053)
217. E. Quinoa, Y. Kakou, P. Crews. J. Org. Chem. 53, 3642 (1988). (http://dx.doi.org/10.1021/jo00250a052)
218. C. W. Jefford, G. Bernardinelli, J. I. Tanaka, T. Higa. Tetrahedron Lett. 37, 159 (1996). (http://dx.doi.org/10.1016/0040-4039(95)02113-2)
219. S. L. Mooberry, G. Tien, A. H. Hernandez, A. Plubrukarn, B. S. Davidson. Cancer Res. 59, 653 (1999).
220. D. E. Pryor, A. O’Brate, G. Bilcer, J. F. Diaz, Y. Wang, Y. Wang, M. Kabaki, M. K. Jung, J. M. Andreu, A. K. Ghosh, P. Giannakakou, E. Hamel. Biochemistry 41, 9109 (2002). (http://dx.doi.org/10.1021/bi020211b)
221. J. Mulzer, E. Ohler. Angew. Chem., Int. Ed. 40, 3842 (2001). (http://dx.doi.org/10.1002/1521-3773(20011015)40:20<3842::AID-ANIE3842>3.0.CO;2-R)
222. I. Paterson, C. De Savi, M. Tudge. Org. Lett. 3, 3149 (2001). (http://dx.doi.org/10.1021/ol010150u)
223. A. K. Ghosh, Y. Wang. J. Am. Chem. Soc. 122, 11027 (2000). (http://dx.doi.org/10.1021/ja0027416)
224. L. M. West, P. T. Northcote, C. N. Battershill. J. Org. Chem. 65, 445 (2000). (http://dx.doi.org/10.1021/jo991296y)
225. K. A. Hood, L. M. West, B. Rouwe, P. T. Northcote, M. V. Berridge, S. J. Wakefield, J. H. Miller. Cancer Res. 62, 3356 (2002).
226. G. R. Pettit, Z. A. Cichacz, F. Gao, M. R. Boyd, J. M. Schmidt. J. Chem. Soc., Chem. Commun. 9, 1111 (1994). (http://dx.doi.org/10.1039/c39940001111)
227. H. Muramatsu, M. Miyauchi, B. Sato, S. Yoshimura. “A novel microtubule-stabilizing agent, WS9885B”, Symposium Papers. Symposium on the Chemistry of Natural Products, Fukuoka, Japan, 40, 487 (1998).
228. C. D. Vanderwal, D. A. Vosburg, S. Weiler, E. J. Sorensen. Org. Lett. 1, 645 (1999). (http://dx.doi.org/10.1021/ol990723r)
229. D. Roux, H. A. Hadi, S. Thoret, D. Guenard, O. Thoison, M. Pais, T. Sevenet. J. Nat. Prod. 63, 1070 (2000). (http://dx.doi.org/10.1021/np0000872)
230. K. C. Nicolaou, F. Roschangar, D. Vourloumis. Angew. Chem., Int. Ed. 37, 2014 (1998). (http://dx.doi.org/10.1002/(SICI)1521-3773(19980817)37:15<2014::AID-ANIE2014>3.0.CO;2-2)
231. C. R. Harris, S. J. Danishefsky. J. Org. Chem. 64, 8434 (1999).
232. K. H. Altmann, G. Bold, G. Caravatti, A. Florsheimer, V. Guagnano, M. Wartmann. Bioorg. Med. Chem. Lett. 10, 2765 (2000). (http://dx.doi.org/10.1016/S0960-894X(00)00555-2)
233. M. Wartmann, K. H. Altmann. Curr. Med. Chem. Anticancer Agents 2, 123 (2002). (http://dx.doi.org/10.2174/1568011023354489)
234. K. H. Altmann. Mini Rev. Med. Chem. 3, 149 (2003). (http://dx.doi.org/10.2174/1389557033405269)
235. S. J. Stachel, K. Biswas, S. J. Danishefsky. Curr. Pharm. Des. 7, 1277 (2001). (http://dx.doi.org/10.2174/1381612013397410)
236. P. Fumoleau, B. Coudert, N. Isambert, E. Ferrant. Ann. Oncol. 18, 9 (2007). (http://dx.doi.org/10.1093/annonc/mdm173)
237. K. H. Altmann. Curr. Pharm. Des. 11, 1595 (2005). (http://dx.doi.org/10.2174/1381612053764715)
238. S. Goodin, M. P. Kane, E. H. Rubin. J. Clin. Oncol. 22, 2015 (2004). (http://dx.doi.org/10.1200/JCO.2004.12.001)
239. D. G. I. Kingston. Chem. Biol. 11, 153 (2004).
240. J. Jimenez-Barbero, F. Amat-Guerri, J. P. Snyder. Curr. Med. Chem. Anti-cancer Agents 2, 91 (2002). (http://dx.doi.org/10.2174/1568011023354416)
241. J. D. Winkler, P. H. Axelsen. Bioorg. Med. Chem. Lett. 6, 2963 (1996). (http://dx.doi.org/10.1016/S0960-894X(96)00555-0)
242. I. Ojima, S. Chakravarty, T. Inoue, S. Lin, L. He, S. B. Horwitz, S. D. Kuduk, S. J. Danishefsky. Proc. Natl. Acad. Sci. USA 96, 4256 (1999). (http://dx.doi.org/10.1073/pnas.96.8.4256)
243. L. He, P. G. Jagtap, D. G. I. Kingston, H. J. Shen, G. A. Orr, S. B. Horwitz. Biochemistry 39, 3972 (2000). (http://dx.doi.org/10.1021/bi992518p)
244. P. Giannakakou, R. Gussio, E. Nogales, K. H. Downing, D. Zaharevitz, B. Bollbuck, G. Poy, D. Sackett, K. C. Nicolaou, T. Fojo. Proc. Natl. Acad. Sci. USA 97, 2904 (2000). (http://dx.doi.org/10.1073/pnas.040546297)
245. J. H. Nettles, H. Li, B. Cornett, J. M. Krahn, J. P. Snyder, K. H. Downing. Science 305, 866 (2004). (http://dx.doi.org/10.1126/science.1099190)
246. Z. Wang, D. Yang, A. K. Mohanakrishnan, P. E. Fanwick, P. Nampoothiri, E. Hamel, M. Cushman. J. Med. Chem. 43, 2419 (2000). (http://dx.doi.org/10.1021/jm0001119)
247. S. J. Haggarty, T. U. Mayer, D. T. Miyamoto, R. Fathi, R. W. King, T. J. Mitchison, S. L. Schreiber. Chem. Biol. 7, 275 (2000). (http://dx.doi.org/10.1016/S1074-5521(00)00101-0)
248. U. Klar, H. Graf, O. Schenk, B. Rohr, H. Schulz. Bioorg. Med. Chem. Lett. 8, 1397 (1998). (http://dx.doi.org/10.1016/S0960-894X(98)00226-1)
249. Y. Shintani, T. Tanaka, Y. Nozaki. Cancer Chemother. Pharmacol. 40, 513 (1997). (http://dx.doi.org/10.1007/s002800050695)
250. R. M. Borzilleri, Z. Zheng, R. J. Schmidt, J. A. Johnson, S. H. Kim, J. D. DiMarco, C. R. Fairchild, J. Z. Gougoutas, F. Y. F. Lee, B. H. Long, G. D. Vite. J. Am. Chem. Soc. 122, 8890 (2000). (http://dx.doi.org/10.1021/ja001899n)
251. S. Hegde, M. Schmidt. Ann. Rep. Med. Chem. 43, 455 (2008). (http://dx.doi.org/10.1016/S0065-7743(08)00025-0)
252. J. Ho, L. Zhang, L. Todorova, F. Whillans, P. Corey-Lisle, Y. Yuan. J. Managed Care Pharm. 15, 467 (2009).
253. X. M. Cheng. Ann. Rep. Med. Chem. 29, 331 (1994). (http://dx.doi.org/10.1016/S0065-7743(08)60747-2)
254. X. M. Cheng. Ann. Rep. Med. Chem. 31, 337 (1996). (http://dx.doi.org/10.1016/S0065-7743(08)60473-X)
255. P. W. Erhardt. In Analog-Based Drug Discovery, J. Fischer, R. Ganellin (Eds.), pp. 233–246, Wiley-VCH, Weinheim (2006).
256. P. W. Erhardt. “Drug discovery”, in: Advanced Pharmacology, K. A. Bachmann, M. Hacker, W. Messer (Eds.), pp. 475–560, Elsevier, Oxford (2009).
257. T. N. K. Raju. Lancet 355, 1022 (2000). (http://dx.doi.org/10.1016/S0140-6736(05)74775-9)
258. C. G. Wermuth. J. Med. Chem. 47, 1303 (2004). (http://dx.doi.org/10.1021/jm030480f)

Pure and Applied Chemistry

Navigation

PAC Archives

RSS Feeds

Highlights

Analogue-based drug discovery: Contributions to medicinal chemistry principles and drug design strategies. Microtubule stabilizers as a case in point (Special Topic Article)

References

Pure and Applied Chemistry

Navigation

Search PAC

PAC Archives

RSS Feeds

Highlights

Analogue-based drug discovery: Contributions to medicinal chemistry principles and drug design strategies. Microtubule stabilizers as a case in point (Special Topic Article)

References